Logo image of BBBY

BED BATH & BEYOND INC (BBBY) Stock Fundamental Analysis

NASDAQ:BBBY - Nasdaq - US0758961009 - Common Stock - Currency: USD

0.0751  -0.03 (-27.09%)

After market: 0.0665 -0.01 (-11.45%)

Fundamental Rating

1

Taking everything into account, BBBY scores 1 out of 10 in our fundamental rating. BBBY was compared to 121 industry peers in the Specialty Retail industry. Both the profitability and financial health of BBBY have multiple concerns. BBBY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BBBY had negative earnings in the past year.
BBBY had a negative operating cash flow in the past year.
In the past 5 years BBBY reported 4 times negative net income.
In the past 5 years BBBY always reported a positive cash flow from operatings.
BBBY Yearly Net Income VS EBIT VS OCF VS FCFBBBY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M -500M 1B 1.5B

1.2 Ratios

The profitability ratios for BBBY are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BBBY Yearly ROA, ROE, ROICBBBY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300

1.3 Margins

BBBY has a worse Gross Margin (26.14%) than 68.57% of its industry peers.
In the last couple of years the Gross Margin of BBBY has declined.
The Profit Margin and Operating Margin are not available for BBBY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.8%
GM growth 5Y-2.32%
BBBY Yearly Profit, Operating, Gross MarginsBBBY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

BBBY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BBBY has been reduced compared to 1 year ago.
The debt/assets ratio for BBBY is higher compared to a year ago.
BBBY Yearly Shares OutstandingBBBY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
BBBY Yearly Total Debt VS Total AssetsBBBY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B

2.2 Solvency

BBBY has an Altman-Z score of 3.26. This indicates that BBBY is financially healthy and has little risk of bankruptcy at the moment.
BBBY has a better Altman-Z score (3.26) than 66.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 3.26
ROIC/WACCN/A
WACC4.61%
BBBY Yearly LT Debt VS Equity VS FCFBBBY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.73 indicates that BBBY may have some problems paying its short term obligations.
BBBY's Current ratio of 0.73 is on the low side compared to the rest of the industry. BBBY is outperformed by 91.43% of its industry peers.
BBBY has a Quick Ratio of 0.73. This is a bad value and indicates that BBBY is not financially healthy enough and could expect problems in meeting its short term obligations.
BBBY has a worse Quick ratio (0.17) than 87.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.17
BBBY Yearly Current Assets VS Current LiabilitesBBBY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B

More info and screens

1

3. Growth

3.1 Past

BBBY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -4525.00%.
Looking at the last year, BBBY shows a very negative growth in Revenue. The Revenue has decreased by -26.37% in the last year.
BBBY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.42% yearly.
EPS 1Y (TTM)-4525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1360%
Revenue 1Y (TTM)-26.37%
Revenue growth 3Y-13.2%
Revenue growth 5Y-8.42%
Sales Q2Q%-32.95%

3.2 Future

BBBY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.25% yearly.
Based on estimates for the next years, BBBY will show a decrease in Revenue. The Revenue will decrease by -9.66% on average per year.
EPS Next Y-953.41%
EPS Next 2Y-136.28%
EPS Next 3Y-52.57%
EPS Next 5Y18.25%
Revenue Next Year-29.72%
Revenue Next 2Y-22.24%
Revenue Next 3Y-15.39%
Revenue Next 5Y-9.66%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BBBY Yearly Revenue VS EstimatesBBBY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BBBY Yearly EPS VS EstimatesBBBY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BBBY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BBBY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BBBY Price Earnings VS Forward Price EarningsBBBY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BBBY Per share dataBBBY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

A cheap valuation may be justified as BBBY's earnings are expected to decrease with -52.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-136.28%
EPS Next 3Y-52.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BBBY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BED BATH & BEYOND INC

NASDAQ:BBBY (5/2/2023, 8:17:46 PM)

After market: 0.0665 -0.01 (-11.45%)

0.0751

-0.03 (-27.09%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)01-10 2023-01-10/bmo
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change0%
Ins Owners1.66%
Ins Owner Change0%
Market Cap32.15M
Analysts42.22
Price Target2.22 (2856.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-57.7%
DP-0.02%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-65.31%
Min EPS beat(2)-70.36%
Max EPS beat(2)-60.26%
EPS beat(4)0
Avg EPS beat(4)-792.45%
Min EPS beat(4)-2939.03%
Max EPS beat(4)-60.26%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.14%
Min Revenue beat(2)-7.82%
Max Revenue beat(2)-4.45%
Revenue beat(4)0
Avg Revenue beat(4)-5.09%
Min Revenue beat(4)-7.82%
Max Revenue beat(4)-2.92%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)47.46%
PT rev (3m)32.62%
EPS NQ rev (1m)10.13%
EPS NQ rev (3m)23.46%
EPS NY rev (1m)5.33%
EPS NY rev (3m)-24.1%
Revenue NQ rev (1m)-2.96%
Revenue NQ rev (3m)-1.4%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-7.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.62
EYN/A
EPS(NY)-6.03
Fwd EYN/A
FCF(TTM)-2.46
FCFYN/A
OCF(TTM)-1.42
OCFYN/A
SpS14.51
BVpS-1.87
TBVpS-1.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.14%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.8%
GM growth 5Y-2.32%
F-Score2
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 143.21%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.17
Altman-Z 3.26
F-Score2
WACC4.61%
ROIC/WACCN/A
Cap/Depr(3y)85.11%
Cap/Depr(5y)94.28%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1360%
EPS Next Y-953.41%
EPS Next 2Y-136.28%
EPS Next 3Y-52.57%
EPS Next 5Y18.25%
Revenue 1Y (TTM)-26.37%
Revenue growth 3Y-13.2%
Revenue growth 5Y-8.42%
Sales Q2Q%-32.95%
Revenue Next Year-29.72%
Revenue Next 2Y-22.24%
Revenue Next 3Y-15.39%
Revenue Next 5Y-9.66%
EBIT growth 1Y-878.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-144892%
EBIT Next 3Y-581.03%
EBIT Next 5Y246.71%
FCF growth 1Y-428.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-215.43%
OCF growth 3Y-73.11%
OCF growth 5Y-55.67%